Summary by Moomoo AI
Shanghai Fosun Pharma (Group) Co., Ltd. ("Fosun Pharma") announced on October 30, 2024 that it provided guarantees for its subsidiary. Fosun Pharma provided joint liability guarantee for the RMB 50 million working capital loan application made by its subsidiary Fosun Health to Shanghai Rural Commercial Bank, and provided the same guarantee for the special M&A loan of up to RMB 160 million applied by the Fosun Pharma industry to China Everbright Bank. The guarantee was within the scope authorized at the 2023 shareholders' meeting and within the approved quota range by the shareholders' meeting. As of the date of the announcement, the actual external guarantee amount of Fosun Pharma Group was approximately RMB 30,734.04 million, accounting for approximately 67.27% of the net assets attributable to the shareholders of the listed company audited at the end of 2023. The announcement pointed out that the risk of this guarantee is relatively controllable, necessary, and reasonable.
